insights_auto
Nega BMRN tushdi 2,51%?
Batafsil oʻrganishchevron_right
BMRN:NASDAQ
Biomarin Pharmaceutical Inc
54,81Â US$
arrow_downward
-2,51%(-1,41) 1K
7-okt, 14:46:25 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBMRN tikeri uchun statistika yaratilmoqda...
Ochish
56,05Â US$
Yuqori
56,60Â US$
Past
54,76Â US$
Bozor kapitali
10,61Â mlrd
Oʻrtacha hajm
2,01Â mln
Hajmi
916,78Â ming
P/E koeffitsiyenti
147,76
52 haftalik eng yuqori
70,98Â US$
52 haftalik eng past
49,26Â US$
Aksiya boʻyicha daromad
0,37Â US$
Beta
0,22
Muomaladagi aksiyalar
193,57Â mln
Xodimlar soni
3Â ming
Ochish
56,05Â US$
Yuqori
56,60Â US$
Past
54,76Â US$
Bozor kapitali
10,61Â mlrd
Oʻrtacha hajm
2,01Â mln
Hajmi
916,78Â ming
P/E koeffitsiyenti
147,76
52 haftalik eng yuqori
70,98Â US$
52 haftalik eng past
49,26Â US$
Aksiya boʻyicha daromad
0,37Â US$
Beta
0,22
Muomaladagi aksiyalar
193,57Â mln
Xodimlar soni
3Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Zacks
·
3 soat oldin
FDA Grants Priority Review to BridgeBio's Dwarfism Drug Filing
AD HOC NEWS
·
16 soat oldin
BioMarin flags USD 283 million charge. BioMarin stock loses 1.83 percent.
TradingView
·
20 soat oldin
BioMarin Q3 financial results to see IPR&D expense impact of $283M
PR Newswire
·
1 kun oldin
BioMarin Appoints Cara Bauer as Chief People Officer
Profil
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria.
Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
Biomarin Pharmaceutical Inc haqida
CEOAlexander Hardy
Xodimlar soni3,22Â ming
Asos solinganmar 1997
Bosh ofislarSan Rafael, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytbiomarin.com